𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mitochondria as a target in treatment

✍ Scribed by Marie-Céline Frantz; Peter Wipf

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
504 KB
Volume
51
Category
Article
ISSN
0893-6692

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting mitochondria as a therapeutic
Targeting mitochondria as a therapeutic target in cancer
✍ Charles E. Wenner 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 1 views

## Abstract Knowledge of re‐programming in cancer cells with metabolic differences from their normal counterparts has resulted in new examination of therapeutic approaches. Several studies of the role of tumor mitochondria in cancer have led to the development of non‐genotoxic therapies which targe

Mitochondria-bound hexokinase as target
Mitochondria-bound hexokinase as target for therapy of malignant gliomas
✍ Stéphane Oudard; Florence Poirson; Laurent Miccoli; Yveline Bourgeois; Anne Vass 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 806 KB

Hexokinase plays an important role in glucose-utilizing tissues like normal brain and cancers. In these tissues, hexokinase (HK) is mainly bound to mitochondria (mHK). Our objectives were to evaluate total HK (tHK) activity and mHK fraction in gliomas and to determine whether mHK binding could be ta

Mitochondria as the target for mildronat
Mitochondria as the target for mildronate's protective effects in azidothymidine (AZT)-induced toxicity of isolated rat liver mitochondria
✍ Jolanta Pupure; Maria A. S. Fernandes; Maria S. Santos; António J. M. Moreno; Iv 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 2 views

## Abstract Previously mildronate, an aza‐butyrobetaine derivative, was shown to be a cytoprotective drug, through its mechanism of action of inhibition of carnitine palmitoyltransferase‐1, thus protecting mitochondria from long‐chain fatty acid accumulation and subsequent damage. Recently in an az

Caspases as treatment targets in stroke
Caspases as treatment targets in stroke and neurodegenerative diseases
✍ Jörg B. Schulz; Michael Weller; Michael A. Moskowitz 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 975 KB

Apoptosis is one of the most exciting and intensely investigated areas of biology and medicine today. Cysteine proteases called caspases serve as the executioners of apoptosis, a form of cell suicide. Hypoxic/ischemic cell death proceeds in part, by apoptosis, particularly within the periinfarct zon

β-secretase as a target for the treatmen
β-secretase as a target for the treatment of Alzheimer's disease
✍ Martin Citron 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB 👁 1 views

## Abstract Finding inhibitors of the first step of the amyloid cascade, Aβ~42~ generation, is a major goal of Alzheimer's disease drug development. Two target protease activities, β‐and γ‐secretase, were detected more than 10 years ago but progress in this area has been slow because the enzymes we

Vitamin E analogues as mitochondria-targ
Vitamin E analogues as mitochondria-targeting compounds: From the bench to the bedside?
✍ Yan Zhao; Jiri Neuzil; Kun Wu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

## Abstract Despite considerable effort focusing on designing and finding efficient anti‐cancer drugs over the last decade, little progress has been achieved, in particular in case of highly recalcitrant malignancies. Also, since there is a trend suggesting that deaths from cancers may be more freq